Benefit from Adjuvant TKIs Versus TKIs Plus Chemotherapy in EGFR-Mutant Stage III-pN2 Lung Adenocarcinoma
Qi-wen Li, Li Ma, B. Qiu, Yu-ming Wen, W. Liang, Wanming Hu, N. Chen, Tian Zhang, Shuangbing Xu, Lingjuan Chen, M. Guo, Yi Zhao, Songran Liu, J. Guo, Junye Wang, Siyu Wang, Xin Wang, Q. Pang, H. Long, Hui Liu
Current Oncology